{{PBB|geneid=3976}}
'''Leukemia inhibitory factor''', or '''LIF''', is an [[interleukin 6]] class [[cytokine]] that affects [[cell (biology)|cell]] growth by inhibiting differentiation. When LIF levels drop, the cells differentiate.

==Function==
LIF derives its name from its ability to induce the terminal [[cellular differentiation|differentiation]] of [[myeloid leukemia|myeloid leukemic]] cells, thus preventing their continued growth. Other properties attributed to the cytokine include: the growth promotion and cell differentiation of different types of target cells, influence on [[bone]] [[metabolism]], [[cachexia]], [[neural development]], [[embryogenesis]] and [[inflammation]]. [[p53]] regulated LIF has been shown to facilitate [[Implantation (human embryo)|implantation]] in the mouse model and possibly in humans.<ref>{{cite journal |url=http://www.nature.com/nature/journal/v450/n7170/abs/nature05993.html
|journal=Nature |date=November 29, 2007 
|title=p53 regulates maternal reproduction through LIF
|author=Wenwei Hu, Zhaohui Feng, Angelika K. Teresky1, Arnold J. Levine
|volume=450
|issue=7170
|pages=721–724
|doi=10.1038/nature05993
 |pmid=18046411}}</ref> It has been suggested that recombinant human LIF might help to improve the implantation rate in women with unexplained infertility.<ref>{{cite journal|last=Aghajanova|title=Leukemia inhibitory factor and human embryo implantation|pmid=15731310|year=2004|first1=L|volume=1034|pages=176–83|doi=10.1196/annals.1335.020|journal=Annals of the New York Academy of Sciences}}</ref>

==Binding/activation==
LIF binds to the specific LIF [[receptor (biochemistry)|receptor]] ([[LIFR]]-α) which forms a [[heterodimer]] with a specific subunit common to all members of that family of receptors, the [[GP130]] signal transducing subunit. This leads to activation of the [[Janus kinase|JAK]]/[[STAT protein|STAT]] (Janus kinase/[[Signal transduction|signal transducer]] and activator of [[Transcription (genetics)|transcription]]) and [[MAPK]] ([[mitogen]] activated [[protein]] [[kinase]]) [[biochemical cascade|cascades]].{{citation needed|date=December 2012}}

==Expression==
LIF is normally expressed in the trophectoderm of the developing embryo, with its receptor LIFR expressed throughout the [[inner cell mass]]. As embryonic stem cells are derived from the inner cell mass at the blastocyst stage, removing them from the inner cell mass also removes their source of LIF.

==Use in stem cell culture==
Removal of LIF pushes stem cells toward [[cellular differentiation|differentiation]], but they retain their proliferative potential or pluripotency. Therefore LIF is used in mouse embryonic [[stem cell]] culture. It is necessary to maintain the stem cells in an undifferentiated state, however genetic manipulation of embryonic stem cells allows for LIF independent growth, notably overexpression of the gene [[Nanog]]. 

LIF is not required for culture of human embryonic stem cells.<ref>{{cite journal |author=Kawahara Y, Manabe T, Matsumoto M, Kajiume T, Matsumoto M, Yuge L |title=LIF-Free Embryonic Stem Cell Culture in Simulated Microgravity |journal=PLoS ONE |volume=4 |issue=7 |pages=e6343 |year=2009 |pmid=19626124 |pmc=2710515 |doi=10.1371/journal.pone.0006343 |url=http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0006343 |editor1-last=Zwaka |editor1-first=Thomas}}</ref><ref>{{cite web |url=http://www.geneticsandsociety.org/article.php?id=5197 |title=CGS : PTO Finds Stem Cell Patent Anticipated, Obvious in Light of 'Significant Guideposts' |work= |accessdate=}}</ref>

==References==
{{reflist}}

==Further reading==
{{refbegin | 2}}
{{PBB_Further_reading 
| citations = 
*{{cite journal  | author=Patterson PH |title=Leukemia inhibitory factor, a cytokine at the interface between neurobiology and immunology |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=91 |issue= 17 |pages= 7833–5 |year= 1994 |pmid= 8058719 |doi=10.1073/pnas.91.17.7833  | pmc=44497  }}
*{{cite journal  | author=Aghajanova L |title=Leukemia inhibitory factor and human embryo implantation |journal=Ann. N. Y. Acad. Sci. |volume=1034 |issue=  |pages= 176–83 |year= 2005 |pmid= 15731310 |doi= 10.1196/annals.1335.020 }}
*{{cite journal  | author=Králícková M, Síma P, Rokyta Z |title=Role of the leukemia-inhibitory factor gene mutations in infertile women: the embryo-endometrial cytokine cross talk during implantation--a delicate homeostatic equilibrium |journal=Folia Microbiol. (Praha) |volume=50 |issue= 3 |pages= 179–86 |year= 2005 |pmid= 16295654 |doi=10.1007/BF02931563  }}
*{{cite journal  | author=Stahl J, Gearing DP, Willson TA, ''et al.'' |title=Structural organization of the genes for murine and human leukemia inhibitory factor. Evolutionary conservation of coding and non-coding regions |journal=J. Biol. Chem. |volume=265 |issue= 15 |pages= 8833–41 |year= 1990 |pmid= 1692837 |doi=  }}
*{{cite journal  | author=Bazan JF |title=Neuropoietic cytokines in the hematopoietic fold |journal=Neuron |volume=7 |issue= 2 |pages= 197–208 |year= 1991 |pmid= 1714745 |doi=10.1016/0896-6273(91)90258-2  }}
*{{cite journal  | author=Lowe DG, Nunes W, Bombara M, ''et al.'' |title=Genomic cloning and heterologous expression of human differentiation-stimulating factor |journal=DNA |volume=8 |issue= 5 |pages= 351–9 |year= 1989 |pmid= 2475312 |doi=10.1089/dna.1.1989.8.351  }}
*{{cite journal  | author=Sutherland GR, Baker E, Hyland VJ, ''et al.'' |title=The gene for human leukemia inhibitory factor (LIF) maps to 22q12 |journal=Leukemia |volume=3 |issue= 1 |pages= 9–13 |year= 1989 |pmid= 2491897 |doi=  }}
*{{cite journal  | author=Mori M, Yamaguchi K, Abe K |title=Purification of a lipoprotein lipase-inhibiting protein produced by a melanoma cell line associated with cancer cachexia |journal=Biochem. Biophys. Res. Commun. |volume=160 |issue= 3 |pages= 1085–92 |year= 1989 |pmid= 2730639 |doi=10.1016/S0006-291X(89)80114-7  }}
*{{cite journal  | author=Gough NM, Gearing DP, King JA, ''et al.'' |title=Molecular cloning and expression of the human homologue of the murine gene encoding myeloid leukemia-inhibitory factor |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=85 |issue= 8 |pages= 2623–7 |year= 1988 |pmid= 3128791 |doi=10.1073/pnas.85.8.2623  | pmc=280050  }}
*{{cite journal  | author=Williams RL, Hilton DJ, Pease S, ''et al.'' |title=Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells |journal=Nature |volume=336 |issue= 6200 |pages= 684–7 |year= 1989 |pmid= 3143916 |doi= 10.1038/336684a0 }}
*{{cite journal  | author=Moreau JF, Donaldson DD, Bennett F, ''et al.'' |title=Leukaemia inhibitory factor is identical to the myeloid growth factor human interleukin for DA cells |journal=Nature |volume=336 |issue= 6200 |pages= 690–2 |year= 1989 |pmid= 3143918 |doi= 10.1038/336690a0 }}
*{{cite journal  | author=Yamaguchi M, Miki N, Ono M, ''et al.'' |title=Inhibition of growth hormone-releasing factor production in mouse placenta by cytokines using gp130 as a signal transducer |journal=Endocrinology |volume=136 |issue= 3 |pages= 1072–8 |year= 1995 |pmid= 7867561 |doi=10.1210/en.136.3.1072  }}
*{{cite journal  | author=Schmelzer CH, Harris RJ, Butler D, ''et al.'' |title=Glycosylation pattern and disulfide assignments of recombinant human differentiation-stimulating factor |journal=Arch. Biochem. Biophys. |volume=302 |issue= 2 |pages= 484–9 |year= 1993 |pmid= 8489250 |doi= 10.1006/abbi.1993.1243 }}
*{{cite journal  | author=Aikawa J, Ikeda-Naiki S, Ohgane J, ''et al.'' |title=Molecular cloning of rat leukemia inhibitory factor receptor alpha-chain gene and its expression during pregnancy |journal=Biochim. Biophys. Acta |volume=1353 |issue= 3 |pages= 266–76 |year= 1997 |pmid= 9349722 |doi=  }}
*{{cite journal  | author=Hinds MG, Maurer T, Zhang JG, ''et al.'' |title=Solution structure of leukemia inhibitory factor |journal=J. Biol. Chem. |volume=273 |issue= 22 |pages= 13738–45 |year= 1998 |pmid= 9593715 |doi=10.1074/jbc.273.22.13738  }}
*{{cite journal  | author= |title=Toward a complete human genome sequence |journal=Genome Res. |volume=8 |issue= 11 |pages= 1097–108 |year= 1999 |pmid= 9847074 |doi=  10.1101/gr.8.11.1097}}
*{{cite journal  | author=Tanaka M, Hara T, Copeland NG, ''et al.'' |title=Reconstitution of the functional mouse oncostatin M (OSM) receptor: molecular cloning of the mouse OSM receptor beta subunit |journal=Blood |volume=93 |issue= 3 |pages= 804–15 |year= 1999 |pmid= 9920829 |doi=  }}
*{{cite journal  | author=Nakashima K, Yanagisawa M, Arakawa H, ''et al.'' |title=Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300 |journal=Science |volume=284 |issue= 5413 |pages= 479–82 |year= 1999 |pmid= 10205054 |doi=10.1126/science.284.5413.479  }}
*{{cite journal  | author=Dunham I, Shimizu N, Roe BA, ''et al.'' |title=The DNA sequence of human chromosome 22 |journal=Nature |volume=402 |issue= 6761 |pages= 489–95 |year= 1999 |pmid= 10591208 |doi= 10.1038/990031 }}
}}
{{refend}}
{{PDB Gallery|geneid=3976}}

==External links==
* {{MeshName|Leukemia+Inhibitory+Factor}}

{{Interleukins}}

<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes 
| require_manual_inspection = no 
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}

[[Category:Cytokines]]
[[Category:Pharmacology]]
[[Category:Oncology]]